arrow
F

Francesco Bono

neurob center for headache and botulinum toxin therapy clinic center san vitaliano
H指数:38
被引数:4,666

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Migraine in Real-World Clinical Practice: Patient Burden, Healthcare Utilization and Unmet Needs—A Cross-Sectional Analysis of the I-GRAINE Study

偏头痛在真实世界临床实践中的患者负担、医疗资源利用及未满足需求——I-GRAINE研究的横断面分析

2026-09-290
OA
Occupation and education level in functional motor disorders

功能性运动障碍中的职业和教育水平

2026-07-010
PRE
Clinical features of adolescent-onset functional motor disorders in tertiary movement disorders centers

青少年起病的功能性运动障碍在三级运动障碍中心中的临床特征

2026-03-220
OAAI
The Pain in Dystonia Scale (PIDS)-Validation in Craniofacial and Upper Limb Dystonia

肌张力障碍疼痛量表(PIDS)在颅面和上肢肌张力障碍中的验证

2026-02-010
OAAI
Is segmental/multifocal onset a distinct presentation of idiopathic adult-onset dystonia?

节段性/多灶性起病是否是特发性成人起病肌张力障碍的一种独特表现形式?

2025-12-040
PRE
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE)

绘制真实世界偏头痛患者画像:来自意大利国家偏头痛登记系统(I-GRAINE)的社会人口学、生活方式和临床数据的公共卫生见解

2025-10-030
OA
Segmental and Multifocal Isolated Dystonias: Similarities and Differences

节段性及多灶性孤立性肌张力障碍:相似性与差异性

2025-10-011
OAAI
The Complex Pathway of Conventional Investigations before the Diagnosis of Functional Motor Disorders

功能性运动障碍诊断前的复杂检查路径

2025-09-030
OAAI
GIANT: a prospective, multicenter, real-world study on the effectiveness, safety, and tolerability of atogepant in migraine patients with multiple therapeutic failures

GIANT:一项关于在多次治疗失败的偏头痛患者中阿托 gepant 的有效性、安全性和耐受性的前瞻性、多中心、真实世界研究

2025-05-190
OA
Does sex influence the natural history of idiopathic adult-onset dystonia?
2024-03-012
OA
Does thyroid diseases contribute to the natural history of idiopathic adult-onset dystonia? Data from the Italian Dystonia Registry
2024-02-201
PRE
Do cerebrovascular risk factors impact the clinical expression of idiopathic isolated adult-onset dystonia?
2023-10-010
PRE
Regional Targeted Subcutaneous Injection of Botulinum Neurotoxin Type A in Refractory Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study

A型肉毒杆菌神经毒素局部靶向皮下注射治疗难治性慢性偏头痛: 一项随机、双盲、安慰剂对照研究

2023-05-091
OAAI
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
2022-11-0151
OAAI
Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?
2022-08-163
OAAI
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: Friend (fremanezumab in real world study), the first Italian multicenter, prospective real-life study
2021-10-010
PRE